Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantitative MRI Assessment of Myotoxin-Induced Skeletal Muscle Damage of mdx Mice.

Muscle & nerve·2026
Same author

Dystrophins DP71 and DP427 determine cell viability during proliferation and myofibre differentiation.

Cell death & disease·2026
Same author

Daily associations of three types of social control with physical activity, reactance, and mood in romantic couples: a dyadic intensive longitudinal study.

Psychology & health·2026
Same author

Genetic strategies for therapy of Duchenne muscular dystrophy.

Molecular therapy. Nucleic acids·2025
Same author

Proteomics-based evaluation of AAV dystrophin gene therapy outcomes in mdx skeletal muscle.

JCI insight·2025
Same author

The future of gene therapy: Safer vectors, sharper focus: High-profile failures demand deep root cause analysis - but the transformative potential of AAV remains within reach if the field is willing to learn and evolve.

Molecular therapy : the journal of the American Society of Gene Therapy·2025

Related Experiment Video

Updated: Feb 20, 2026

Production of Adeno-Associated Virus Vectors in Cell Stacks for Preclinical Studies in Large Animal Models
07:21

Production of Adeno-Associated Virus Vectors in Cell Stacks for Preclinical Studies in Large Animal Models

Published on: June 30, 2021

7.3K

AAV6 Vector Production and Purification for Muscle Gene Therapy.

Christine L Halbert1, James M Allen1, Jeffrey S Chamberlain2

  • 1Department of Neurology, Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center, University of Washington, Seattle, WA, 98195-7720, USA.

Methods in Molecular Biology (Clifton, N.J.)
|October 26, 2017
PubMed
Summary
This summary is machine-generated.

Adeno-associated virus (AAV) vectors are crucial for gene therapy. This study details optimized protocols for producing AAV6 vectors, enhancing gene transfer efficiency, particularly for muscle tissues.

Keywords:
AAVAAV6AAV9Adeno-associated viral vectorDuchenne muscular dystrophyDystrophinGene therapyMicrodystrophinSystemic delivery

More Related Videos

Production, Purification, and Quality Control for Adeno-associated Virus-based Vectors
09:21

Production, Purification, and Quality Control for Adeno-associated Virus-based Vectors

Published on: January 29, 2019

38.0K
Process Development for the Production and Purification of Adeno-Associated Virus AAV2 Vector using Baculovirus-Insect Cell Culture System
10:31

Process Development for the Production and Purification of Adeno-Associated Virus AAV2 Vector using Baculovirus-Insect Cell Culture System

Published on: January 13, 2022

10.5K

Related Experiment Videos

Last Updated: Feb 20, 2026

Production of Adeno-Associated Virus Vectors in Cell Stacks for Preclinical Studies in Large Animal Models
07:21

Production of Adeno-Associated Virus Vectors in Cell Stacks for Preclinical Studies in Large Animal Models

Published on: June 30, 2021

7.3K
Production, Purification, and Quality Control for Adeno-associated Virus-based Vectors
09:21

Production, Purification, and Quality Control for Adeno-associated Virus-based Vectors

Published on: January 29, 2019

38.0K
Process Development for the Production and Purification of Adeno-Associated Virus AAV2 Vector using Baculovirus-Insect Cell Culture System
10:31

Process Development for the Production and Purification of Adeno-Associated Virus AAV2 Vector using Baculovirus-Insect Cell Culture System

Published on: January 13, 2022

10.5K

Area of Science:

  • Molecular Biology
  • Virology
  • Gene Therapy

Background:

  • Adeno-associated virus (AAV) vectors are widely used for gene transfer in vitro and in vivo.
  • AAV vectors are increasingly employed in clinical gene therapy for various human diseases.
  • Current AAV vector production methods involve co-transfection of transfer and helper plasmids, with yields sensitive to procedural variations.

Purpose of the Study:

  • To describe optimized protocols for generating adeno-associated virus serotype 6 (AAV6) vectors.
  • To improve the efficiency of AAV vector production for gene transfer applications.
  • To highlight the utility of AAV6 vectors for gene delivery to muscle tissues.

Main Methods:

  • Co-transfection of plasmid vectors encoding the transgene of interest and helper genes.
  • Detailed description of protocols for generating AAV6 vectors.
  • Focus on optimizing steps to maximize vector yield.

Main Results:

  • Established protocols for reproducible generation of AAV6 vectors.
  • Demonstrated significant improvements in AAV vector yield through optimized procedures.
  • Confirmed the efficacy of AAV6 vectors for gene transfer into muscle tissues.

Conclusions:

  • Optimized protocols provide a reliable method for producing high-titer AAV6 vectors.
  • These protocols are valuable for advancing gene therapy research and applications, especially for muscle-related disorders.
  • Efficient AAV vector production is critical for the successful clinical translation of gene therapies.